ZYBERNO
Stock Report
Updated Aug 30, 2026

MiniMed Group, Inc. (MMED)

Healthcare • NASDAQ

$20.10

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
17.0/100
POOR BUSINESS
MiniMed Group, Inc. (MMED) scores 17/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.03x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-3.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

MiniMed Group, Inc. (MMED) stock report — Zyberno Score 17/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:20.10
Market Cap:$5.08B

Valuation Multiples (2)

P/B Ratio:1.47x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$5.42B

Price Action & Momentum (1)

% of 52-Week High:96.3%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:-47.0%
Fundamental Growth Rate (g):1.8%

Margin Analysis (1)

Ebitda Margin:-1.9%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.59x
Quick Ratio:1.01x
Cash Ratio:0.01x

Leverage Analysis (3)

Debt To Equity Ttm:0.03x
Debt-to-Equity Ratio:0.03x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:412,000,000.00
Cash And Cash Equivalents:10,000,000.00
Long Term Debt:$184.00M
Net Debt:$335.00M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$3.10B
Cost Of Revenue Ttm:$1.42B

Profitability Breakdown (2)

$1.68B-$190.00M

Bottom Line Performance (3)

-$317.00M
Income Before Tax:-$99.00M
Ebitda Ttm:-60,000,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:114,000,000.00
Sga Expense:309,000,000.00
Income Tax Expense:$12.00M
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:14.4%
Sga To Revenue Percentage:39.1%
Ebitda Margin:-1.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$4.34B
Current Assets:$1.11B
Ppe Net:701,000,000.00
Goodwill:2,256,000,000.00
Intangible Assets:$113.00M

Liability Structure (4)

Total Liabilities:881,000,000.00
Current Liabilities:696,000,000.00
Long Term Debt:$184.00M
Short Term Debt:$161.00M

Equity & Capital (3)

Equity:$3.46B
Retained Earnings:-$116.00M
Common Stock:1,000,000,000.00

Working Capital Items (3)

Accounts Receivable:653,000,000.00
Inventory:408,000,000.00
Accounts Payable:303,000,000.00

Special Items (2)

Contract Liabilities:17,000,000.00
Stock Based Compensation:11,000,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$197.00M-$420.00M

Investment Activities (1)

Investing Cash Flow:-$233.00M

Financing Activities (3)

Financing Cash Flow:$716.00M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:130,000,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$1.25

Revenue & Cash Per Share (2)

Sales Per Share Ttm:12.27
Operating Cash Flow Per Share:-$0.78

Book Value & Capital (2)

Book Value Per Share:$13.69
Cash Per Share:0.04

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.71x
Working Capital Turnover Ttm:7.53x

Receivables Management (2)

Receivables Turnover Ttm:4.75x
Days Sales Outstanding Ttm:76.84

Inventory Management (2)

Inventory Turnover Ttm:3.49x
Days Inventory Outstanding Ttm:104.73

Payables & Cash Cycle (2)

Days Payable Outstanding:77.77
Cash Conversion Cycle:103.79
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:-47.0%
Fundamental Growth Rate (g):1.8%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:MMED
Company Name:MiniMed Group, Inc.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:medium
Volume Category:N/A

Share Structure (3)

Shares Outstanding:252.81M
Shares Outstanding Basic:252.81M
Shares Outstanding Diluted:252.81M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-30 10:47:48 UTC
Data Timestamp:2026-08-30T10:47:48.419865
Scroll to Top